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ABSTRACT
Homologous recombination is essential for the
preservation of genome stability, thereby preventing
cancer. The recombination protein RAD51 drives
DNA strand exchange, which requires the
assembly, rearrangement and disassembly of a
RAD51 filament on DNA, coupled to ATP binding
and hydrolysis. This process is facilitated and
controlled by recombination mediators and acces-
sory factors. Here, we have employed a range of
single molecule techniques to determine the influ-
ence of the C-terminal RAD51 interaction domain
(CTRD) of the breast cancer tumor suppressor
BRCA2 on intrinsic aspects of RAD51-DNA inter-
actions. We show that at high concentration the
CTRD entangles RAD51 filaments and reduces
RAD51 filament formation in a concentration de-
pendent manner. It does not affect the rate of
filament disassembly measured as the loss of fluor-
escent signal due to intrinsic RAD51 protein dissoci-
ation from double-stranded DNA (dsDNA). We
conclude that, outside the context of the full-length
protein, the CTRD does not reduce RAD51 dissoci-
ation kinetics, but instead hinders filament forma-
tion on dsDNA. The CTRDs mode of action is most
likely sequestration of multiple RAD51 molecules
thereby rendering them inactive for filament forma-
tion on dsDNA.
INTRODUCTION
Double-stranded DNA breaks (DSBs) are severe lesions
that can result in chromosomal rearrangements leading to
cellular senescence or the onset and progression of cancers
(1,2). In S and G2 phases of the cell cycle, homologous
recombination (HR) provides a pathway for the faithful
repair of such lesions (3). HR can be divided in three steps:
pre-synapsis, synapsis and post-synapsis (4). Pre-synapsis
consist of the recognition of a DSB, and the resection of
one strand leaving tailed DNA that is bound by RAD51
to form a nucleoprotein ﬁlament (5,6). During synapsis
this nucleoprotein ﬁlament interacts with the intact sister
chromatid (homology search), and strand invasion occurs
at the site of homology resulting in joint molecule forma-
tion and strand exchange. Post-synapsis is deﬁned as the
events leading to the recovery of lost information by
polymerase-mediated DNA resynthesis and the resolution
of branched DNA structures resulting in two intact chro-
matids (7,8).
Biochemical assays have deﬁned RAD51 recombinase
as the catalyst of synapsis. It forms a helical ﬁlament on
single-stranded DNA (ssDNA) that can drive the DNA
transactions required for HR in vitro. The RAD51 nucleo-
protein ﬁlament will invade a homologous double-
stranded DNA (dsDNA) and forms a joint molecule. To
catalyze strand exchange, the RAD51 nucleoprotein
ﬁlament undergoes dynamic rearrangements that result
in DNA strands exchanging base-paired partners leading
to the formation of a ﬁlament on heteroduplex DNA—
one strand being the invading ssDNA while the other is
the complementary strand of the template DNA. The next
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strand to prime DNA extension by a polymerase. This
stage requires RAD51 removal from the heteroduplex
DNA (9–11), and these dissociation reactions have been
addressed in previous single molecule studies (12–15).
The actions of RAD51 are facilitated by recombination
mediators and controlled by accessory factors (16,17). One
such mediator is the BRCA2 protein which is essential for
efﬁcient HR in mammalian cells (16–18). The role that
BRCA2 plays in maintaining genome stability has been
attributed to its ability to interact directly with RAD51
(19,20). Biochemical studies with BRCA2 peptides have
deﬁned interactions with RAD51 via a series of eight
BRC repeats and a C-terminal domain, designated
C-terminal RAD51 interaction domain [CTRD; previ-
ously referred to as TR2 (21,22)]. This domain contains
a cyclin-dependent kinase phosphorylation site that
modulates RAD51 binding (21,23). The BRC domains,
best characterized by BRC4, which has the highest
afﬁnity for RAD51, interact with RAD51 at the polymer-
ization domain and can thereby disrupt RAD51 ﬁlaments
at concentrations equal to or higher than the RAD51 con-
centration (22–25). The CTRD of BRCA2 interacts with
multimeric RAD51 and can inhibit the destabilization of
RAD51 ﬁlaments caused by the BRC repeats (22,24,25).
In avian cells the CTRD of BRCA2 inﬂuences the persist-
ence of RAD51 in local nuclear accumulations in a
manner consistent with stabilizing RAD51 ﬁlaments
(26). To determine whether the CTRD of BRCA2 might
provide an effect opposite to the BRC repeats, by helping
to stabilize RAD51 ﬁlaments on dsDNA, we used an array
of single-molecule techniques together with ensemble
studies. First, we visualized the effect of the CTRD on
RAD51 dissociation from dsDNA. We observed individ-
ual ﬁlaments formed with ﬂuorescent RAD51 and
quantiﬁed their disassembly in time by ﬂuorescent micros-
copy in a microﬂuidic ﬂow system (12). We then analyzed
the effect of the CTRD on RAD51 nucleoprotein ﬁlament
structure by optical ﬂuorescence microscopy, by scanning
force microscopy imaging (27), and a combination of both
techniques (28). We then analyzed the effect of the CTRD
on RAD51 ﬁlament assembly on dsDNA, following the
extension of individual dsDNA molecules by RAD51
binding, in magnetic tweezers (13,29).
MATERIALS AND METHODS
Protein production
Wild-type and variants of human RAD51 were puriﬁed by
similar procedures, essentially as previously described
(12). Brieﬂy, RAD51 was expressed in bacteria,
precipitated by ammonium sulfate, subsequently dialyzed
and further puriﬁed by Heparin, gel ﬁltration and anion
exchange chromatography. The CTRD peptides were as
described previously (21,22).
Protein labeling
RAD51 was Alexa Fluor 488 labeled on a speciﬁc cysteine
residue using maleimidine chemistry and checked for
activity as previously described (12). The degree of
labeling was 0.75 ﬂuorophores per RAD51.
Surface tethering and visualization of ﬂuorescent
ﬁlaments in buffer
Flow cells, constructed from #1 glass cover slips
(Menzel-Glaser) separated by a double-layer Paraﬁlm in
a custom holder, were prepared as follows: Neutravidin
(Pierce) was introduced at 1mg/ml and allowed to interact
for 30min. After removal of excess Neutravidin, the ﬂow
cell was washed and blocked with 2mg/ml acetylated
BSA, 2mg/ml a-casein, 10mM DTT, 50mM Tris–HCl
(pH 7.5), 30mM KCl and 10% glycerol.  phage
dsDNA was biotinylated at one end and labeled with
digoxygenin at the other by annealing biotinylated oligo-
nucleotides to CosL (50-P-AAG TCG CCG CCC dR-bio
dR-bio-bioTEG-30) and to CosR (50-P-GGG CGG
CGdRDig CCT CGG CGC CCG GCC GCG dTDigAA
ACG CGG CCG GGC GCC GG-30) as described (30).
Filaments were assembled in a 20ml reaction mixture con-
taining 91 pM (molecules) of  phage dsDNA, 1.4mM
RAD51, 50mM Tris–HCl (pH 7.5), 1mM ATP, 2mM
CaCl2, 1mM DTT and 60mM KCl. Reaction mixtures
were incubated at 37 C for 30min. When indicated
4.8nM CTRD peptide was added and the reaction
mixtures incubated for another 15min (RAD51:CTRD
of 291:1). Alternatively, CTRD and RAD51 were
incubated for 15min before addition of the other
reaction components. All reaction mixtures were diluted
by addition of 380ml CaCl2/ATP buffer [50 mM Tris–HCl
(pH 7.5), 1mM ATP, 2mM CaCl2, 1mM DTT and
60mM KCl], and injected into a ﬂow cell. For the
CTRD reactions the CaCl2/ATP buffer also included
4.8nM CTRD, changing the RAD51:CTRD ratio to
15:1. The ﬂow was stopped for  10min to allow inter-
action of the biotynilated DNA with the Neutravidin
surface. Unbound ﬁlaments were ﬂushed by ﬂow of
CaCl2/ATP buffer, including 4.8nM CTRD if present in
assembly reaction. Dissociation was triggered by
switching to Mg
2+/ATP buffer [50 mM Tris–HCl (pH
7.5), 1mM ATP, 10mM MgCl2, 1mM DTT and 60mM
KCl]. Hydrodynamic ﬂow was controlled with a precision
pump (Harvard Apparatus). Dynamic visualization of
ﬁlaments was performed with a Nikon 60  or 100 
(NA 1.45) TIRF objective in a Nikon TE2000U inverted
microscope equipped with a Cascade 512B CCD camera
(Princeton Instruments) driven by Metamorph software
(Molecular Devices). Excitation was performed with a
mercury arc lamp. Intensity measurements were obtained
deﬁning regions of interest around the construct contour
length in all planes, tracking them over time and correct-
ing for background. The data were plotted using Origin
software.
Combined ﬂuorescence and scanning force microscopy
RAD51 ﬁlaments were assembled as described above.
After 30min incubation at 37 C, the CTRD or a
phosphorylated CTRD (P-CTRD) was added to a ﬁnal
concentration of 45nM (RAD51:CTRD of 31:1).
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HCl (pH 7.5), 1mM ATP, 2mM CaCl2, 1mM DTT,
60mM KCl and 45nM CTRD for ﬂow cell experiments,
changing the RAD51:CTRD to 1.5:1. Ten microliter
aliquots of the dilution were supplemented with 3 pM
red ﬂuorescent (580/605) 40nm diameter beads
(FluoSpheres microspheres from Invitrogen) and de-
posited on a freshly cleaved Mica. Fluorescent images
were obtained with the set-up described above and
correlated with topographic images obtained with a
NanoWizard II scanner (JPK instruments) as
described (28).
Electrophoretic mobility shift assays
Reactions were performed in a ﬁnal volume of 20ml con-
taining 50-end Alexa Fluor 532-labeled 66bp dsDNA (31)
at 66nM (nucleotides), 1mM RAD51, 50mM Tris–HCl
(pH 7.5), 1mM DTT, 60mM KCl, 2mM CaCl2 and
1mM ATP (32). After 5min incubation at 37 C, the
CTRD peptide was added to the indicated concentrations
in a 2ml volume and incubations were continued for a
further 15min at 37 C. Reaction mixtures were then sup-
plemented with 3ml 30% glycerol and 24ml were
fractionated by 0.8% agarose gel electrophoresis in 0.5 
Tris–Borate for 2.5h at 60V at 4 C. Gels were analyzed
using a T9600 typhoon scanner exciting the dye-coupled
DNA with a 532nm laser and detecting emission intensity
using a the 555nm BP 20 ﬁlter at 800V PMT, 3mm focal
plane. Images obtained were analyzed with ImageQuant
version 5.2 (Molecular Dynamics) or Image J.
Scanning force microscopy
Nucleoprotein ﬁlaments were formed in 10ml reaction
mixtures containing 7.5mM 3-kb dsDNA (concentration
in bp), 2.5mM human RAD51, 25mM HEPES–KOH (pH
7.5), 5mM CaCl2, 2mM ATP and 30mM KCl. Reaction
mixtures were incubated at 37 C for 1h and then placed
on ice. When indicated, 500nM CTRD was added to
RAD51 for 15min at 37 C before addition of the other
components (RAD51:TR2=5:1). Aliquots of the
reaction mixtures were then diluted 15-fold in 10mM
HEPES–KOH (pH 7.5) and 10mM MgCl2 and deposited
on freshly cleaved mica, scanned and analyzed as previ-
ously described (27).
DNA constructs for magnetic tweezers
A 7.3-kb dsDNA construct was prepared as described
previously (33).
Magnetic tweezers assay
The magnetic tweezers set-up used in these experiments
was described previously (34). By using image processing,
10-nm position accuracy of the bead was obtained in all
three dimensions. To exclude the effect of thermal drift, all
positions were measured relative to beads ﬁxed to the
bottom of the ﬂow cell. DNA constructs carrying a
magnetic bead at one end were anchored to the bottom
of a ﬂow cell. Experiments were started by addition of
RAD51 or RAD51 pre-incubated with the CTRD at the
indicated concentrations, in 50mM NaCl, 50mM Tris–
HCl, pH 7.5, 2mM CaCl2, 1mM ATP. All measurements
were carried out at 25 C.
The nucleation rate dependence on the CTRD concen-
trations was ﬁtted with a model that takes RAD51 nucle-
ation into account. RAD51 nucleation requires multiple
RAD51 monomers according to nRAD51+DNA!
(RAD51)n–DNA, where values of n are reported
between 2.7 and 4.3, indicating that nucleation requires
3–5 RAD51 monomers (13,15). This model leads to a
power-law dependence of the nucleation rate according
to Rnuc / [RAD51]
n. We propose a model where the
CTRD can interact with multiple RAD51 monomers to
reduce the concentration of active RAD51 according to
[RAD51]active=[RAD51] i[CTRD], where i is the
number of RAD51 monomers that a CTRD peptide
binds.
RESULTS
The initial aim was to measure the dissociation kinetics of
RAD51 in the absence and presence of the CTRD of
BRCA2 to determine whether the CTRD played a role
in ﬁlament stabilization.
Filament dissociation
RAD51 ﬁlaments were formed by incubating Alexa Fluor
488 labeled protein with 48-kb  phage dsDNA molecules
in the presence of ATP and CaCl2, conditions that stabil-
ize RAD51 nucleoprotein ﬁlaments (12,27,32). The 
phage dsDNA molecules were biotinylated at one end in
order to tether the nucleoprotein ﬁlaments on the
neutravidin-coated surface of a ﬂow cell, where they
were extended by buffer ﬂow and observed in a ﬂuorescent
microscope. ATPase dependent dissociation of RAD51
from dsDNA was measured as a loss of ﬂuorescent
signal over time, corrected for background. Control
traces in Ca
2+/ATP buffer in absence or presence of a
synthetic CTRD peptide (Figure 1, black hollow circles
and green triangles, respectively) showed that the
RAD51 complex was stable over time and that
the CTRD did not affect the photostability of the
ﬂuorophore. Switching buffer to one containing ATP
and MgCl2 triggered RAD51 dissociation from dsDNA
(12,14). Stabilization of RAD51 ﬁlaments by the CTRD
was expected to slow the kinetics for RAD51 dissociation
(23). As a reference, RAD51 ﬁlaments were assembled in
absence of the CTRD and RAD51 ﬁlament disassembly
was measured over time (Figure 1, black solid circles).
When the CTRD was added at a ratio of
RAD51:CTRD=15:1 to pre-formed ﬁlaments, there
was no detectable effect of the CTRD on RAD51 dissoci-
ation from dsDNA (Figure 1, red solid triangles). The
dissociation data overlap which showed that the rate is
the same and implies that there is no difference in the
way dissociation takes place. A phosphorylated CTRD
peptide (P-CTRD), which does not interact with
RAD51, also did not affect the rate of RAD51 dissoci-
ation signiﬁcantly (Figure 1, grey crosses).
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complexes
To demonstrate that the CTRD peptide can interact with
RAD51–dsDNA complexes under our reaction condi-
tions, we employed electrophoretic mobility shift assays
(EMSA). Using conditions identical to those in the ﬂow
cell before switching to Mg
2+/ATP buffer (i.e. ATPase
suppressing Ca
2+/ATP buffer) complex formation
between RAD51–dsDNA and the CTRD was assessed
using agarose gels (Figure 2). In the ﬂow cell experiment
the ratio RAD51:CTRD was  15:1. Therefore the
amount of the CTRD was varied in a range encompassing
the ratio in the ﬂow cell. A higher amount of RAD51 was
needed to fully shift the short dsDNA (see Supplementary
Figure S1) and therefore the CTRD concentrations were
adjusted to keep the ratios of RAD51:CTRD similar. The
CTRD concentrations used gave RAD51:CTRD ratios of
22:1 (45nM CTRD), 11:1 (91nM CTRD) and 7:1
(137nM CTRD). Figure 2 shows a representative gel
where titration of the CTRD had a minor effect on
dsDNA migration in the controls (lanes 2–4), but
showed clear interaction with the RAD51–dsDNA
complexes by ‘super-shifting’ them in a concentration de-
pendent manner (lanes 6–8). To show speciﬁcity, the
EMSA assay was also performed with P-CTRD, which
includes a phopsphate group at the cyclin-dependent
kinase phosphorylation site (S3291E), that does not
interact with RAD51 (21).This non-interacting P-CTRD
failed to form ternary complexes with the RAD51–
dsDNA complex (Supplementary Figure S2). The assays
conﬁrm that the CTRD interacts with RAD51–dsDNA
complexes at a similar ratio of RAD51:CTRD and in
the same buffer conditions that were used in the ﬂow cell.
CTRD-induced entanglement of RAD51–DNA complexes
Previous biochemical assays indicate that the BRCA2
CTRD stabilizes RAD51 ﬁlaments (23). These
experiments, however, utilized excess of the CTRD with
respect to RAD51. To approach a comparable ratio of
RAD51:CTRD, we increased the CTRD concentration
10-fold with respect to the conditions used for the experi-
ments shown in Figure 1. However, distinctly separated,
ﬂow-stretched ﬁlaments were not observed, even at a
RAD51:CTRD ratio of 1.5:1. Instead round, bright ﬂuor-
escent signals were observed that presumably represented
CTRD-induced entanglement of RAD51–dsDNA
complexes (data not shown). A portion of these RAD51/
CTRD–dsDNA complexes was deposited for imaging
using combined ﬂuorescence and scanning force micros-
copy (SFM). Fluorescence detection allows locating and
identifying the labeled RAD51 and SFM provides nm
resolution structural information of the protein–DNA
complexes (Figure 3). The ﬂuorescent image (Figure 3A)
shows an overlay of a representative complex of RAD51
protein and ﬂuorescent polystyrene beads. The polystyr-
ene beads serve to align the combined ﬂuorescent picture
(Figure 3A) with the topographic image (Figure 3B)
obtained by SFM (28). Analysis of the SFM image
(Figure 3F) revealed that it was indeed an entanglement
of (partial) RAD51 ﬁlaments since the height of the struc-
ture corresponded to single RAD51 ﬁlaments on dsDNA,
while unbound dsDNA was also observed (compare
Figure 3, panel F with E and H, respectively; see
Figure 3D for height traces of the corresponding cross
sections). Entanglement was due to the presence of the
CTRD because in a control experiment using the same
concentration of non-interacting P-CTRD no aggregation
was observed (Figure 3C). Instead regular RAD51 ﬁla-
ments on dsDNA could be seen (compare Figure 3G
with E, corresponding height traces in Figure 3D). In
ﬂow cell experiments without CTRD  15±6 ﬁlaments
on average could be seen in a 40 by 40mm ﬁeld (n=95).
However, at CTRD concentrations above 45nM
 1.5±0.7 intense, round ﬂuorescent signals were
Figure 1. The effect of the CTRD on RAD51 disassembly from indi-
vidual dsDNA molecules in a ﬂow cell. RAD51 disassembly from
dsDNA was measured as loss of ﬂuorescence signal. The CTRD did
not signiﬁcantly inﬂuence the dissociation rate when ATP hydrolysis
was triggered by Mg
2+/ATP. The Ca
2+/ATP control ﬁlaments were also
not affected by the presence of the CTRD. The non-interacting
P-CTRD also did not inﬂuence the dissociation rate signiﬁcantly. The
error bars represent the standard error.
0 45 91 137 0 45 91 137
0 22:1 11:1 7:1
no RAD51 1 µM RAD51
Ratio
RAD51:CTRD
dsDNA
DNA-protein
complexes
1234 5678 l a n e
nM CTRD
Figure 2. CTRD interaction with RAD51 ﬁlaments. Electrophoretic
mobility shift assays (EMSA) were preformed with ﬂuorescently
end-labeled dsDNA and RAD51 (1mM), CTRD or a combination of
both using agarose gels to separate unbound from bound DNA.
Reaction mixtures contained the indicated concentrations of the
CTRD. Interaction of the CTRD with the RAD51–dsDNA complexes
is evident in lanes 6–8 as ‘super-shifting’ of the complex in a CTRD
concentration dependent manner.
Nucleic Acids Research, 2011,Vol.39, No. 15 6561observed in the same size ﬁeld (n=9). Since the same
amount of DNA and RAD51 were used in both ﬁlament
formation reactions this suggests that one such aggregate
consists on average of  10 ﬁlaments.
Filaments formed in the presence of CTRD are
qualitatively distinct
In the RAD51 dissociation experiments in the ﬂow cell
(such as plotted in Figure 1) the CTRD was added after
RAD51 ﬁlament formation and incubated for an add-
itional 15min at 37 C. Examples of such ﬁlaments are
shown in the upper left picture in Figure 4A. These ﬁla-
ments appear similar as ﬁlaments with RAD51 alone (12);
the ﬂuorescence covers most of the DNA contour with
some gaps. In previous experiments the CTRD inﬂuenced
ﬁlaments when pre-incubated with RAD51 for 15min at
37 C before addition of DNA (21,23). Therefore we
prepared ﬁlaments after pre-incubation of the CTRD
with RAD51. Strikingly, RAD51 ﬁlaments were distinct
from the ﬁlaments formed in the absence of the CTRD
(compare Figure 4B to A). The ﬁlaments formed after
pre-incubation appeared to be less complete, consisting
of shorter ﬁlament patches covering less DNA
(Figure 4B). Thus a change in the order of addition
revealed that a pre-incubation of the CTRD with
RAD51 is interfering with extensive ﬁlament formation.
The presence of the CTRD during ﬁlament formation
results in incomplete, ‘patchy’ ﬁlaments, which could not
be analyzed reliably in dissociation experiments. Therefore
we decided to analyze these ﬁlaments using SFM.
SFM analysis of ﬁlament length in presence of the CTRD
To assess the effect of the CTRD on ﬁlament formation
and structure, nucleoprotein ﬁlaments were formed after
pre-incubation of RAD51 and the CTRD, at a ratio of
5:1, on 3-kb dsDNA were analyzed by SFM (27). The
images did not show a strong difference in appearance
of the control ﬁlaments and those formed in the
presence of the CTRD (data not shown). As RAD51 poly-
merization onto DNA stretches it  50% over regular
B-form length, we compared the contour lengths of
RAD51 ﬁlaments without and with the CTRD
(RAD51:CTRD=5:1). The average elongation of ﬁla-
ments was not much decreased by the presence of the
CTRD (1.4±0.1mm versus 1.29±0.09mm). However,
the distribution of ﬁlament lengths was clearly skewed
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Figure 3. CTRD-induced RAD51 ﬁlament entanglement. Fluorescent (A) and SFM (B, C, E) images of RAD51 ﬁlaments on phage  dsDNA.
Filaments were either assembled in the presence of 45nM CTRD (A, B, F), 45nM of phosphorylated control peptide P-CTRD (C and G) or without
peptide (E). (A) Image of combined ﬂuorescence signals from RAD51 and ﬂuorosphere markers. The bright green object in the center of the image in
panel A was scanned for nanometer topography. (B) The topographic image reveals entangled RAD51 ﬁlaments. (F) A higher resolution picture of
the red boxed area in panel B shows stretches of single ﬁlament (cyan cross section) and partial ﬁlaments revealing DNA stretches not bound by
RAD51. (D) Plot of height and width of the cross sections taken in scan F (blue trace) and G (red trace) comparing them to control depositions of
RAD51 ﬁlaments in absence of peptide (panel E, black trace) and dsDNA alone (panel H, magenta trace). Images A–C are 10 by 10mm, the white
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6562 Nucleic Acids Research, 2011,Vol.39, No. 15towards shorter ﬁlaments in the presence of the CTRD
(Figure 5). A reduction in contour lengths could be
attributed to reduced RAD51 polymerization onto
DNA. Filament formation is a dynamic process consisting
of nucleation and extension (growth) and the CTRD
could speciﬁcally inﬂuence one or the other of these
processes.
The CTRD decreases RAD51 ﬁlament assembly rate in
magnetic tweezers measurements
RAD51 ﬁlament assembly was followed on individual
dsDNA molecules (7.3kb) in magnetic tweezers (13,33).
The DNA molecules were tethered between a magnetic
bead and the surface of a ﬂow cell. A force of 7±2 pN
was applied by a pair of magnets and video microscopy
was used to measure the end-to-end distance of the DNA
tether. Due to the known extension of dsDNA upon
RAD51 binding an increase in tether length can be
directly correlated to the polymerization of RAD51 onto
dsDNA. Assembly of a RAD51 ﬁlament in the absence of
the CTRD resulted in a DNA tether length increase from
2.54±0.04mm to 3.76±0.07mm corresponding to a
1.48-fold extension (Figure 6, black curves), similar to
previous observations (13). RAD51 ﬁlament assembly
was, however, very sensitive to pre-incubation of
RAD51 with the CTRD in a concentration dependent
manner. At a ratio of RAD51:CTRD=12.5:1 ﬁlament
assembly was already markedly reduced (Figure 6, cyan
curves).
The assembly proﬁles obtained by magnetic tweezers
experiments were analyzed by ﬁtting to Monte Carlo
simulations, assuming a binding size of 3bp per RAD51
monomer and ﬁlament nucleation and extension by
RAD51 pentamers as described previously (13,29,33).
Nucleation is the dominant step in ﬁlament formation.
For the simulations the extension rate was linked to the
nucleation rate by setting the co-operativity number o to a
value of 100 in line with results of ﬁts with cooperativity as
a free independent ﬁt parameter and previous results (29).
The Monte Carlo ﬁtting procedure yielded nucleation
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Figure 4. Appearance of RAD51 ﬁlaments in ﬂow cell experiments. RAD51 nucleoprotein ﬁlaments (A–C) and their corresponding kymographs
showing disassembly over time after ATP hydrolysis has been triggered (A 1/2, B 3/4, C 5/6). Fluorescent signal was acquired as described previously
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line towards the bottom of the kymograph represents a 20s step for a total time of 45min. The upper panels show the typical appearance of RAD51
ﬁlaments. The middle panels show ﬁlaments formed after pre-incubation of RAD51 and the CTRD peptide. These ﬁlaments appear patchy as
evidenced by stretches of bare DNA and less protein bound per DNA molecule. The lower panels show ﬁlaments formed after pre-incubation with
the phosphorylated control peptide (P-CTRD). These ﬁlaments appear similar to the ones without peptide as they are not patchy.
Nucleic Acids Research, 2011,Vol.39, No. 15 6563rates of RAD51 at different CTRD concentrations (Figure
7). The validity of this approach for extracting ﬁlament
assembly rates was demonstrated by plotting averaged
assembly curves for each CTRD concentration against a
rescaled time axis (inset, Figure 6). The time axis was
normalized based on rates found after ﬁtting to Monte
Carlo simulations. After normalizing, the ﬁlament
assembly proﬁles at different CTRD concentrations
overlapped (inset, Figure 6), conﬁrming that the shape
of the assembly curves is similar and that these curves
differ in only one parameter, namely the assembly rate.
Filament assembly was strongly decreased by the presence
of the CTRD in a concentration dependent manner. The
inﬂuence of the CTRD on ﬁlament assembly rates
indicated that the amount of RAD51 available for
ﬁlament assembly was decreased in the presence of the
CTRD. When RAD51 nucleation rates are plotted
against CTRD concentration (Figure 7), the power-law
shape of the ﬁt indicates that the CTRD interacts with
multimeric RAD51, calculated to be on average three to
four RAD51 monomers (see ‘Materials and Methods’
section) consistent with previous observations (23,25).
DISCUSSION
Here we have addressed the effect of the CTRD domain of
BRCA2 on the key entity in HR, the RAD51 ﬁlament.
RAD51 nucleoprotein ﬁlaments are dynamic structures
undergoing constant rearrangements coupled to ATP hy-
drolysis. Either suppressing ATP hydrolysis or mechanical
protein–protein interactions could stabilize RAD51 ﬁla-
ments. The CTRD of BRCA2 was proposed to stabilize
RAD51 ﬁlaments by stabilization of protein–protein inter-
actions, acting as a bridge over the RAD51 monomer
interface in one model (23,25). In the context of full-length
BRCA2, the CTRD domain is expected to have a role
modulating RAD51 activity based on observations that
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Figure 6. RAD51 ﬁlament assembly in real time. RAD51 ﬁlament
assembly was measured as changes in the length of a DNA, tethered
in magnetic tweezers, over time. Different CTRD concentrations are
indicated by color: [CTRD]=0 (black), [CTRD]=2nM (yellow),
[CTRD]=6nM (green), [CTRD]=12nM (cyan) and [CTRD]=
60nM (red). Filament assembly was measured on several individual
DNA molecules (n=5–12) for each CTRD concentration. RAD51
and the CTRD were pre-incubated for 15min at 37 C. RAD51 con-
centration was constant at 150nM in all experiments. The inset shows
the average growth proﬁle for each concentration of the CTRD
rescaled by t/t*, where t*=1/g and g is the nucleation rate determined
from ﬁtting to Monte Carlo simulations.
Figure 7. Effect of the CTRD on ﬁlament assembly rate. The nucle-
ation rates of RAD51 ﬁlaments were extracted from ﬁtting Monte
Carlo simulations to the data from Figure 6 at a constant cooperativity
number of o=100. Error bars indicate the standard deviations in the
nucleation rates found by ﬁtting the assembly proﬁles of Figure 6 at
each CTRD concentration. A model used to ﬁt nucleation rates (see
‘Materials and Methods’ section) resulted in a best ﬁt for the number of
RAD51 monomers interacting with CTRD of 3.5±0.4 (black trace).
For comparison a model assuming a CTRD interaction with monomer-
ic RAD51 (dark grey trace), and a model assuming an interaction of
monomeric RAD51 with multiple CTRDs (light gray trace) is shown.
Figure 5. Contour length of RAD51 ﬁlaments formed in the presence
and absence of the CTRD. The contour length of RAD51 ﬁlaments,
from images obtained by SFM, were measured and plotted in histo-
grams for control ﬁlaments (left) and ﬁlaments formed in the presence
of the CTRD (right). The y-axis indicates the number of ﬁlaments,
while the contour length in micrometer with a binning step of 50nm
is plotted along the x-axis. The left panel displays the histogram for the
control ﬁlaments; the right panel for ﬁlaments formed after
pre-incubation of RAD51 with CTRD at a ratio of 5:1.
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RAD51 binding (21,26). However, we observe no effect of
the isolated CTRD domain on ﬁlament disassembly rates
by direct visualization of RAD51 dissociation from
-phage dsDNA. Although this result suggests the
model based on CTRD bridging RAD51 monomers in a
ﬁlament to prevent access of BRC-repeats might not hold
up it is not contradictory to previous work showing that
RAD51 ﬁlament disassembly by BRC-repeat peptides is
inhibited by the CTRD (22–25). That observation could
also be due to CTRD induced RAD51 ﬁlament entangle-
ment or aggregation as discussed below. Direct stabiliza-
tion by altering inherent RAD51 dissociation was not
previously tested (22–25). Since RAD51 dissociation in
our set-up is dependent on ATP hydrolysis (12,14), we
can conclude that the presence of the CTRD (at a ratio
of RAD51:CTRD=15:1) does not suppress the ATPase
activity of RAD51, nor is its interaction with the ﬁlament
strong enough to slow dissociation in a ﬂow cell set-up.
The absence of an effect of the CTRD peptide on
RAD51 ﬁlament stability could have been due to
absence of interaction with the ﬁlaments formed in our
conditions. Although the amount of peptide available
precluded adding it to the buffer ﬂow during dissociation
the persistence of CTRD-induced ﬁlament entanglement
in the same ﬂow conditions argues that the peptide does
not simply dissociate. The EMSA experiments show that
the CTRD interacts with RAD51–dsDNA complexes in a
concentration-dependent manner in the same starting
reaction conditions used in the ﬂow cell i.e. Ca
2+/ATP.
Because these gel assays required RAD51 at higher con-
centrations than in the ﬂow cell, the concentration of the
CTRD was also adjusted so that the ratio of
RAD51:CTRD was 22:1, 11:1 and 7:1, encompassing the
15:1 ratio used in the ﬂow cell. Thus, while the CTRD
interacts with RAD51 ﬁlaments, it does not inﬂuence
ﬁlament disassembly rates, suggesting that ﬁlament stabil-
ity is not affected.
Several lines of evidence indicate that at higher concen-
tration, or ratios to RAD51, CTRD causes entanglement
of RAD51 ﬁlaments. Flow cell experiments were at-
tempted at a higher protein concentration, such as
required for the EMSA. At CTRD concentration of
45nM, the lowest concentration showing an effect in the
EMSA and corresponding to a ﬁnal ratio of
RAD51:CTRD of 1.5:1 in the ﬂow cell, ﬁlaments could
not be analyzed by ﬂow stretching. The observation of
round, intense, ﬂuorescent signals, which sometimes
untangled upon ATP hydrolysis, indicated that the long
RAD51 ﬁlaments on -phage dsDNA may have
aggregated in these conditions. Combined ﬂuorescence
and SFM imaging revealed that the large, brightly ﬂuor-
escent objects are indeed CTRD-induced entangled
RAD51 ﬁlaments that include stretches of naked DNA
(Figure 3). This aggregation of RAD51–DNA complexes
at higher CTRD concentration would have a detrimental
effect on interactions of other proteins with the ﬁlament
structure. Indeed, CTRD-induced ﬁlament aggregation
has also been noted in other studies (23). This could
explain the previously observed protective effect of the
CTRD on ﬁlaments exposed to high concentrations of
BRC4 that will otherwise disrupt ﬁlaments (23,25). The
correlation between stronger CTRD:RAD51 interaction
and longer persistence of local nuclear accumulations of
RAD51 is also consistent with CTRD-induced ﬁlament
aggregation or entanglement (26).
By contrast, the CTRD–RAD51 interaction did inhibit
ﬁlament assembly. Interaction of RAD51 and the CTRD
before adding dsDNA had a strong effect on ﬁlament ap-
pearance, even at a ﬁnal CTRD concentration of  5nM
(ratio RAD51:CTRD=291:1). The nucleoprotein
ﬁlament formed had more frequent and larger gaps of
naked DNA between protein-bound patches (compare
Figure 4 upper and lower panel), an appearance we refer
to as ‘patchy’. Furthermore, the concentrations used here
were equivalent to the ones in the disassembly experi-
ments, indicating that the lack of an effect on ﬁlament
disassembly in the ﬂow cell was not due to concentrations
of the CTRD insufﬁcient for interaction with RAD51.
RAD51ﬁlaments, formed on 3 kbp-long dsDNA, in the
presence of the CTRD are also somewhat shorter than
control ﬁlaments (Figure 5). The average DNA extension
by ﬁlament pre-incubated with the CTRD is only  70%
that of the control ﬁlaments (29 versus 40%). In the
magnetic tweezers assay, RAD51 ﬁlament assembly was
very sensitive to pre-incubation with the CTRD. Rates
progressively decreased with increasing CTRD concentra-
tion (Figure 6). The shape of the assembly curves reﬂects
the interplay between nucleation and extension events in
RAD51 DNA-binding to assemble a ﬁlament (13). The
average assembly curves for each CTRD concentration
have the same shape, implying that the CTRD has not
changed the way RAD51 extends dsDNA as reﬂected in
the ratio of nucleation to extension. These data all support
the idea that the CTRD inhibits RAD51 ﬁlament
assembly by effectively reducing the active RAD51
concentration.
Alternatively, the CTRD could speciﬁcally cap nascent
ﬁlament patches and block further extension. This would
produce ﬁlaments with different appearance, shorter
protein patches with a length correlating to the CTRD
concentration, and would require more nucleation events
to cover the DNA. However, ﬁlaments formed after
pre-incubating RAD51 and the CTRD at a 5:1 ratio
appeared mostly regular, without obvious gaps or
multiple kinks that would indicate reduced extension
events. Additionally, ﬁlament capping by the CTRD is
expected to inhibit dissociation and to change the ratio
of nucleation to extension in ﬁlament assembly kinetics.
None of these effects were observed, thus the CTRD inter-
action with RAD51 apparently does not cap ﬁlaments.
The RAD51 assembly reactions show a power-law de-
pendence of the nucleation rate on CTRD concentration.
This was used to determine the stoichiometry of RAD51
affected by the CTRD. Assuming a nucleation unit of 5
RAD51 monomers (13,29) the power-law ﬁt had a
minimum for least squares error i=3.5±0.4, indicating
that one CTRD reacts on average with three to four
RAD51 monomers. This is in accordance with the obser-
vation that the CTRD binds multimeric RAD51 in
solution (23,25) and suggests that the mode of the
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from ﬁlament assembly.
Inactivation of three to four RAD51 monomers for
ﬁlament formation by CTRD binding can explain
altered ﬁlament appearance as well as reduced assembly
rates. The alternative model, that extending RAD51
ﬁlament patches are capped in RecX-like fashion is
unlikely (35–37). Overall, our data are in accordance
with recent work on the full-length BRCA2 (38–40) and
previous studies with BRC peptides (22–25,41–43). Those
studies show that BRCA2 and its fragments interact with
RAD51–dsDNA complexes and that BRCA2 modulates
RAD51 DNA-binding such that ﬁlaments preferentially
form on ssDNA over dsDNA. Here we show that not
only BRC repeats (23,41–43) but also the CTRD of
BRCA2 interferes with RAD51 ﬁlament formation on
dsDNA. These two peptide portions of BRCA2 differ in
details of how they affect RAD51 ﬁlaments. Stimulation
of RAD51 binding to ssDNA speciﬁcally occurs when
ATP hydrolysis is possible (41,42). In contrast, the effect
we report of the CTRD on RAD51 ﬁlaments does not
require ATP hydrolysis, as reactions occur in conditions
where RAD510s ATPase activity is suppressed. The inter-
action stoichiometry of the two domains is also different.
The BRC repeat forms a complex with RAD51 at a 1:1
ratio (24,44,45). The CTRD interacts with RAD51
multimers (23,24), and we show it affects ﬁlaments forma-
tion at substoichiometric amounts. How these different
interaction phenomena are manifested in the context of
full-length BRCA2 is an important question that can
now be addressed. The CTRD domain could work in
concert with the BRC domains modulating DNA
binding towards ssDNA.
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